Evidence map›Paper›PMID 33434439›Full record

ArticleDiabetes technology & therapeutics2021

Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features.

Halis Kaan Akturk, Robert Dowd, Kaushik Shankar, Mark Derdzinski

Open access · hybridAbstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Insights into the effective use of the Smart MDI system: Data from the first 1852 type 1 diabetes users.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Halis Kaan AkturkBarbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.
Robert DowdDexcom, Inc., San Diego, California, USA.
Kaushik ShankarDexcom, Inc., San Diego, California, USA.
Mark DerdzinskiDexcom, Inc., San Diego, California, USA.
Dexcom (United States) · USUniversity of Colorado Anschutz Medical Campus · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1HypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringHumansRetrospective StudiesBlood GlucoseCLARITYContinuous glucose monitoringDexcomReal-world dataType 1 diabetes

Identifiers

PMID33434439
PMCPMC7957382
OpenAlexW3118287506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.